Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News HCW Biologics Inc HCWB

Healthcare Biotechnology
HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions such as long-haul COVID... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:HCWB)

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

GlobeNewswire 10 hours ago

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

GlobeNewswire November 18, 2024

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

GlobeNewswire November 18, 2024

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights

GlobeNewswire November 14, 2024

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

GlobeNewswire August 23, 2024

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire August 14, 2024

HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire May 15, 2024

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

GlobeNewswire April 1, 2024

HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights

GlobeNewswire November 14, 2023
View More News ››

Opinion & Analysis (NDAQ:HCWB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:HCWB)

HCW Biologics and WY Biotech Enter License, Research, and Co

NEWS: $HCWB HCW Biologics and WY Biotech Enter License, Research, and Co-Development Agreement for Immunotherapeutic Product...
whytestocks - November 18, 2024

HCW Biologics Inc. (NASDAQ:HCWB): Navigating the Challenges

http://beyondspx.com/2024/08/01/hcw-biologics-inc-nasdaqhcwb-navigating-the-challenges-of-inflammaging-and-advancing-innovative...
MikeTester - August 2, 2024
View more Bullboard ››

Leading Edge Materials Corp.

Leading Edge Materials Corp.

Leading Edge Materials Corp. is a Canada-based company focused on developing a portfolio of critical raw material projects ...
View More »